Free Trial
→ Collect $7k per month from Tesla’s SECRET dividend (From Investors Alley) (Ad) Free ZNTL Stock Alerts

Zentalis Pharmaceuticals (ZNTL) SEC Filings & 10K Form

Zentalis Pharmaceuticals logo
$2.32 -0.15 (-6.07%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$2.21 -0.11 (-4.57%)
As of 02/21/2025 07:32 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Zentalis Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
02/14/2025
11:13 AM		EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/11/2025
7:06 PM		Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/05/2025
5:29 PM		EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:30 PM		Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:31 PM		Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:32 PM		Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/05/2025
5:33 PM		Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:37 PM		EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
3:06 PM		MILLENNIUM MANAGEMENT LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G
02/03/2025
6:12 PM		Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:13 PM		Paul Andrea (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
6:14 PM		Lackner Mark (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
11:44 AM		Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/31/2025
9:09 AM		VANGUARD GROUP INC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/29/2025
8:18 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/22/2025
9:08 AM		Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/08/2025
5:49 PM		Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
12/10/2024
11:42 AM		Walters William T (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G
12/06/2024
10:44 AM		FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
12/03/2024
6:02 PM		EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/03/2024
6:02 PM		Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
4:44 PM		Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:45 PM		EASTLAND JULIA MARIE (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:46 PM		Bruns Ingmar (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
11/13/2024
4:46 PM		Myers Scott Dunseth (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/13/2024
7:06 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
1:47 PM		EVENTIDE ASSET MANAGEMENT, LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
11/04/2024
1:16 PM		VANGUARD GROUP INC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
10/31/2024
7:59 PM		HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
11:50 AM		STATE STREET CORP (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
10/07/2024
10:37 AM		FMR LLC (Filed by)
Zentalis Pharmaceuticals (Subject)
Form SC 13G/A
10/04/2024
5:01 PM		Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/16/2024
6:02 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:01 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:03 AM		Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
06/21/2024
4:06 PM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
4:07 PM		Johnson David Michael (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:09 PM		Kariuki Enoch (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/21/2024
4:11 PM		Skvarka Jan (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
6:00 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/31/2024
5:27 PM		Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)

Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?

That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y
05/31/2024
5:28 PM		Gallagher Cam (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2024
6:04 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
6:16 AM		Zentalis Pharmaceuticals (Filer)
Form DEFA14A
05/29/2024
6:33 AM		Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/29/2024
6:34 AM		Walker Luke Nathaniel (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:46 PM		HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/09/2024
6:47 PM		HAUSMAN DIANA (Reporting)
Zentalis Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/07/2024
6:03 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
6:05 AM		Zentalis Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
3:34 PM		Zentalis Pharmaceuticals (Filer)
Form DEF 14A
04/29/2024
3:36 PM		Zentalis Pharmaceuticals (Filer)
Form DEFA14A
04/11/2024
6:00 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/11/2024
6:02 AM		Vultaggio Vincent (Reporting)
Zentalis Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2024
3:30 PM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/29/2024
4:14 PM		Zentalis Pharmaceuticals (Filer)
Form S-3ASR
02/29/2024
4:20 PM		Zentalis Pharmaceuticals (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2024
6:04 AM		Zentalis Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
6:08 AM		Zentalis Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ZNTL) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Buy NVDA Now?
After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...
Chaikin Analytics | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored
The Real Hillbilly Elegy
The mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...
Porter & Company | Sponsored